(Q38270640)

English

Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study

scientific article

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Catherine Thieblemont

8

object named as

Catherine Thieblemont

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Florence Nguyen-Khac

19

object named as

Florence Nguyen-Khac

0 references

Hélène Merle-Béral

20

object named as

Hélène Merle-Béral

0 references

Caroline Besson

object named as

Caroline Besson

27

0 references

object named as

Fabrice Carrat

24

0 references

object named as

Patrice Cacoub

5

0 references

Olivier Hermine

object named as

Olivier Hermine

26

0 references

13

object named as

Stanislas Pol

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

4

object named as

Laurent Alric

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Danielle Canioni

2

object named as

Danielle Canioni

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

author name string

Jean-Marie Michot

1

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Henda Driss

3

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Felipe Suarez

6

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

David Sibon

7

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Jehan Dupuis

9

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Benjamin Terrier

10

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Cyrille Feray

11

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Hervé Tilly

12

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Véronique Leblond

14

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Catherine Settegrana

15

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Pascaline Rabiega

16

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Yoann Barthe

17

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Houria Hendel-Chavez

18

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Françoise Berger

21

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Thierry Molina

22

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Frédéric Charlotte

23

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Frédéric Davi

25

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

ANRS HC-13 Lympho-C Study Group

28

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

publication date

24 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

American Journal of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

90

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

197-203

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d'Etude des Lymphomes de l'Adulte programs

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

Clinical characteristics and outcome for hepatitis C virus-positive diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

Biologic and clinical significance of cryoglobulins. A report of 86 cases

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

Hepatitis C virus-induced vasculitis: therapeutic options.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

Revised response criteria for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

A non-parametric graphical representation of the relationship between survival and the occurrence of an event: application to responder versus non-responder bias

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

Impact of Cryoglobulinemic Syndrome on the Outcome of Chronic Hepatitis C Virus Infection: A 15-Year Prospective Study.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

Immunoglobulin Gene Mutations and Frequent Use of VH1-69 and VH4-34 Segments in Hepatitis C Virus-Positive and Hepatitis C Virus-Negative Nodal Marginal Zone B-Cell Lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

T(14;18) translocation in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FAJH.23889

21 January 2018

Identifiers

10.1002/AJH.23889

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

release_f7eka5juy5f4zbibn3tsg3xeqe

1 reference

https://api.fatcat.wiki/v0/release/f7eka5juy5f4zbibn3tsg3xeqe

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38270640&oldid=2042089274"